Top Suppliers:I want be here
Related CAS#:
196309-76-9 19542-67-7
1424-48-2 134733-55-4
128253-31-6 348086-71-5
2275774-60-0 2468783-75-5
1631164-25-4 1152781-51-5
1158522-08-7 940364-43-2
134104-43-1 131615-57-1
6906-52-1 930439-75-1
1018584-77-4 2436555-57-4
1375289-11-4 2680670-89-5

196309-76-9

196309-76-9 structure
196309-76-9 structure
Name (E)-3-(4-tert-butylphenyl)sulfonylprop-2-enenitrile
Synonyms 2-Propenenitrile, 3-[[4-(1,1-dimethylethyl)phenyl]sulfonyl]-, (2E)-
(2E)-3-[(4-tert-Butylphenyl)sulfonyl]acrylonitrile
(2E)-3-{[4-(2-Methyl-2-propanyl)phenyl]sulfonyl}acrylonitrile
Bay 11-7085
(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile
(E)-3-(4-t-Butylphenylsulfonyl)-2-propenenitrile
Description BAY 11-7085 is an inhibitor of NF-κB activation and phosphorylation of IκBα; it stabilizes IκBα with an IC50 of 10 μM.
Related Catalog
Target

NF-κB

IκB-α:10 μM (IC50)

In Vitro BAY 11-7085 inhibits TNFa-induced surface expression of E-selectin, VCAM-1, and ICAM-1with IC50 values in the range of 5-10 μM. BAY 11-7085 stabilizes IκBα in a dose-dependent manner with an IC50 value of approximately 10 μM. There is a clear correlation between the concentration of drug that stabilized IκBα, the concentration that inhibits nuclear levels of NF-kB, and the concentration that inhibits adhesion molecule expression[1]. BAY 11-7085 has been shown to inhibit cell proliferation and induce apoptosis of a variety of cells. BAY 11-7085 (ECSCs) significantly inhibits the cell proliferation and DNA synthesis of ovarian endometriotic cyst stromal cells and induces apoptosis and the G0/G1 phase cell cycle arrest of these cells. BAY 11-7085 induces apoptosis of ECSCs by suppressing antiapoptotic proteins, and that caspase-3-, -8-, and -9-mediated cascades are involved in this mechanism[2].
In Vivo BAY 11-7085 acts as an anti-inflammatory agent in both the rat carrageenan paw and the rat adjuvant arthritis model. It demonstrates a dose-dependent reduction in swelling in the rat carrageenan paw model[1].
Cell Assay ECSCs cells are incubated for 48 h with BAY 11-7085 (0.01-10 μM). Thereafter, 20 μL of WST-1 dye are added to each well, and the cells are further incubated for 4 h. All experiments are performed in the presence of 10% FBS. Cell proliferation is evaluated by measuring absorbance at 540 nm[2].
Animal Admin Rats: 1% suspension of carrageenan in distilled water is administered to rats as 0.1 mL subplantar injection into the footpad of the right hind paw. One hour prior to injection, rats are treated intraperitoneally with vehicle (polyethylglycol 400 diluted 1:5 in 5% bovine serum albumin/water) or a fine suspension of compound 2 (1, 5, or 50 mg/kg) in vehicle. A positive control group is also included in which rats are pretreated with 20 mg/kg ibuprofen. Four hours after carrageenan administration, the volume of the injected paw is measured. Edema volumes are determined[1].
References

[1]. Pierce JW, et al. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesionmolecule expression show anti-inflammatory effects in vivo. J Biol Chem. 1997 Aug 22;272(34):21096-103.

[2]. Nasu K, et al. Application of the nuclear factor-kappaB inhibitor BAY 11-7085 for the treatment of endometriosis: an in vitro study. Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E16-23.
Density 1.1±0.1 g/cm3
Boiling Point 407.1±45.0 °C at 760 mmHg
Melting Point 80-82℃
Molecular Formula C13H15NO2S
Molecular Weight 249.329
Flash Point 200.0±28.7 °C
Exact Mass 249.082352
PSA 66.31000
LogP 2.51
Vapour Pressure 0.0±0.9 mmHg at 25°C
Index of Refraction 1.535
Storage condition Store at +4°C
Water Solubility DMSO: >25 mg/mL, soluble
Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
RIDADR NONH for all modes of transport
WGK Germany 3
RTECS UD1312500
HS Code 29309090

Chemsrc provides CAS#:196309-76-9 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 196309-76-9 | Chemsrc address: https://m.chemsrc.com/en/baike/750920.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved